Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.120 | 11 | 119278211 | missense variant | T/A;C | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.882 | 0.120 | 11 | 119278211 | missense variant | T/A;C | snv |
|
0.010 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
0.851 | 0.320 | 11 | 119278162 | splice acceptor variant | AAAG/- | del |
|
0.700 | 0 | ||||||||||||
|
0.882 | 0.120 | 11 | 119278211 | missense variant | T/A;C | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.827 | 0.080 | 11 | 119278182 | missense variant | A/C;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.807 | 0.240 | 11 | 119278181 | missense variant | T/A;C | snv | 8.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases | 0.700 | 0 | ||||||||||
|
0.807 | 0.240 | 11 | 119278181 | missense variant | T/A;C | snv | 8.0E-06 |
|
Behavior and Behavior Mechanisms | 0.700 | 0 | ||||||||||
|
0.851 | 0.320 | 11 | 119278162 | splice acceptor variant | AAAG/- | del |
|
Behavior and Behavior Mechanisms | 0.700 | 0 | |||||||||||
|
0.925 | 0.160 | 11 | 119278165 | splice acceptor variant | G/C;T | snv |
|
0.700 | 1.000 | 7 | 2010 | 2017 | |||||||||
|
0.807 | 0.240 | 11 | 119278181 | missense variant | T/A;C | snv | 8.0E-06 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 11 | 119278220 | missense variant | T/C;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
0.882 | 0.120 | 11 | 119278211 | missense variant | T/A;C | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.851 | 0.320 | 11 | 119278162 | splice acceptor variant | AAAG/- | del |
|
0.700 | 0 | ||||||||||||
|
0.851 | 0.320 | 11 | 119278162 | splice acceptor variant | AAAG/- | del |
|
0.700 | 0 | ||||||||||||
|
0.882 | 0.320 | 11 | 119278508 | splice acceptor variant | A/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 4 | 2009 | 2012 | ||||||||
|
0.807 | 0.240 | 11 | 119278181 | missense variant | T/A;C | snv | 8.0E-06 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.080 | 11 | 119278182 | missense variant | A/C;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 0.080 | 11 | 119206455 | missense variant | G/A | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.827 | 0.080 | 11 | 119278182 | missense variant | A/C;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 0.040 | 11 | 119301826 | 3 prime UTR variant | A/G | snv | 0.24 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 11 | 119208283 | intron variant | A/G | snv | 0.23 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 11 | 119226075 | intron variant | T/G | snv | 0.26 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 11 | 119274564 | intron variant | A/G | snv | 0.27 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 11 | 119273438 | intron variant | G/T | snv | 0.59 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.240 | 11 | 119278181 | missense variant | T/A;C | snv | 8.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 |